메뉴 건너뛰기
Nervenarzt
Volumn 82, Issue 6, 2011, Pages 764-767
Abrupt switch from extended-release oxcarbazepine to eslicarbazepine acetate;Abrupter austausch von retardiertem oxcarbazepin gegen eslicarbazepinacetat
Author keywords

Epilepsy; Eslicarbazepine acetate; Oxcarbazepine; Safety; Tolerability
Indexed keywords

DRUG METABOLITE; ESLICARBAZEPINE ACETATE; EXTENDED RELEASE OXCARBAZEPINE; MONOHYDROXY DERIVATIVE; OXCARBAZEPINE; SODIUM; UNCLASSIFIED DRUG;
EID: 79959916629     PISSN: 00282804     EISSN: 14330407     Source Type: Journal    
DOI: 10.1007/s00115-010-3177-3     Document Type: Article
Times cited : (13)
References (19)
  • 1
    • 23944448566 scopus 로고    scopus 로고
    • Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects
    • DOI 10.1177/0091270005279364
    • Almeida L, Falcão A, Maia J et al (2005) Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects. J Clin Pharmacol 45:1062-1066 (Pubitemid 41192366)
    • (2005) Journal of Clinical Pharmacology , vol.45 , Issue.9 , pp. 1062-1066
    • Almeida, L.1    Falcao, A.2    Maia, J.3    Mazur, D.4    Gellert, M.5    Soares-Da-Silva, P.6
  • 2
    • 33846184701 scopus 로고    scopus 로고
    • Eslicarbazepine Acetate (BIA 2-093)
    • DOI 10.1016/j.nurt.2006.10.005, PII S1933721306001735, New Antiepileptic Drugs: Discovery, Development, and Update
    • Almeida L, Soares-da-Silva P (2007) Eslicarbazepine acetate (BIA 2-093). Neurother 4:88-96 (Pubitemid 46107316)
    • (2007) Neurotherapeutics , vol.4 , Issue.1 , pp. 88-96
    • Almeida, L.1    Soares-da-Silva, P.2
  • 3
    • 45849105592 scopus 로고    scopus 로고
    • Stereo-selective disposition of S- and R-licarbazepine in mice
    • 2008
    • Alves G, Figueiredo I, Falcão A et al (2008) Stereo-selective disposition of S- and R-licarbazepine in mice. Chirality 2008;20:796-804
    • (2008) Chirality , vol.20 , pp. 796-804
    • Alves, G.1    Figueiredo, I.2    Falcão, A.3
  • 5
    • 79959869753 scopus 로고    scopus 로고
    • Eslicarbazepine acetate: A well-kept secret?
    • Ben-Menachem E (2010) Eslicarbazepine acetate: a well-kept secret? Epilepsy Curr 10:7-8
    • (2010) Epilepsy Curr , vol.10 , pp. 7-8
    • Ben-Menachem, E.1
  • 6
    • 77951297857 scopus 로고    scopus 로고
    • Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy
    • Ben-Menachem E, Gabbai AA, HUfnagel A et al (2010) Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy. Epilepsy Res 89:278-285
    • (2010) Epilepsy Res , vol.89 , pp. 278-285
    • Ben-Menachem, E.1    Gabbai, A.A.2    HUfnagel, A.3
  • 7
    • 0029896080 scopus 로고    scopus 로고
    • A brief questionnaire to screen for quality of life in epilepsy: The QOLIE-10
    • DOI 10.1111/j.1528-1157.1996.tb00612.x
    • Cramer JA, Perrine K, Devinsky O, Meador K (1996) A brief questionnaire to screen for quality of life in epilepsy: the Qolie-10. Epilepsia 37:577-582 (Pubitemid 26169193)
    • (1996) Epilepsia , vol.37 , Issue.6 , pp. 577-582
    • Cramer, J.A.1    Perrine, K.2    Devinsky, O.3    Meador, K.4
  • 8
    • 61849168486 scopus 로고    scopus 로고
    • Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group phase III study
    • Elger C, Halász P, Maia J et al (2009) Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study. Epilepsia 50:454-463
    • (2009) Epilepsia , vol.50 , pp. 454-463
    • Elger, C.1    Halász, P.2    Maia, J.3
  • 9
    • 0345975882 scopus 로고    scopus 로고
    • Systematic screening allows reduction of adverse antiepileptic drug effects: A randomized trial
    • Gilliam FG, Fessler AJ, Baker G et al (2004) Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 62:23-27 (Pubitemid 38082864)
    • (2004) Neurology , vol.62 , Issue.1 , pp. 23-27
    • Gilliam, F.G.1    Fessler, A.J.2    Baker, G.3    Vahle, V.4    Carter, J.5    Attarian, H.6
  • 10
    • 70349972675 scopus 로고    scopus 로고
    • Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures
    • Gil-Nagel A, Lopes-Lima J, Almeida L et al (2009) Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures. Acta Neurol Scand 120:281-287
    • (2009) Acta Neurol Scand , vol.120 , pp. 281-287
    • Gil-Nagel, A.1    Lopes-Lima, J.2    Almeida, L.3
  • 11
    • 0035005884 scopus 로고    scopus 로고
    • Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine
    • DOI 10.1016/S0920-1211(01)00231-5, PII S0920121101002315
    • Hainzl D, Parada A, Soares-da-Silva P (2001) Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine. Epilepsy Res 44:197-206 (Pubitemid 32452229)
    • (2001) Epilepsy Research , vol.44 , Issue.2-3 , pp. 197-206
    • Hainzl, D.1    Parada, A.2    Soares-Da-Silva, P.3
  • 12
    • 78649248897 scopus 로고    scopus 로고
    • Long-term efficacy and safety of eslicarbazepine acetate: Results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy
    • Epub ahead of print
    • Halász P, Cramer JA, Hodoba D et al (2010) Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy. Epilepsia (Epub ahead of print)
    • (2010) Epilepsia
    • Halász, P.1    Cramer, J.A.2    Hodoba, D.3
  • 13
    • 0035310336 scopus 로고    scopus 로고
    • Synthesis, anticonvulsant properties and pharmacokinetic profile of novel 10,11-dihydro-10-oxo-5H-dibenz/b,f/azepine-5-carboxamide derivatives
    • Learmonth DA, Benes J, Parada A et al (2001) Synthesis, anticonvulsant properties and pharmacokinetic profile of novel 10,11-dihydro-10-oxo-5H-dibenz/ b,f/azepine-5-carboxamide derivatives. Eur J med Chem 36:227-236
    • (2001) Eur J Med Chem , vol.36 , pp. 227-236
    • Learmonth, D.A.1    Benes, J.2    Parada, A.3
  • 15
    • 0022930194 scopus 로고
    • The metabolism of 14 C-oxcarbazepine in man
    • Schütz J, Feldmann KF, Faigle JW et al (1986) The metabolism of 14 C-oxcarbazepine in man. Xenobiotica 16:769-778
    • (1986) Xenobiotica , vol.16 , pp. 769-778
    • Schütz, J.1    Feldmann, K.F.2    Faigle, J.W.3
  • 16
    • 70149095970 scopus 로고    scopus 로고
    • Oxcarbazepine extended-release formulation in epilepsy
    • Steinhoff BJ (2009) Oxcarbazepine extended-release formulation in epilepsy. Expert Rev Clin Pharmacol 2:1155-1162
    • (2009) Expert Rev Clin Pharmacol , vol.2 , pp. 1155-1162
    • Steinhoff, B.J.1
  • 17
    • 65349087398 scopus 로고    scopus 로고
    • Verzögert freigesetztes Oxcarbazepin - Überblick und klinische Erfahrungen
    • Steinhoff BJ (2009) Verzögert freigesetztes Oxcarbazepin - Überblick und klinische Erfahrungen. Z Epileptol 22:2-8
    • (2009) Z Epileptol , vol.22 , pp. 2-8
    • Steinhoff, B.J.1
  • 18
    • 70449624785 scopus 로고    scopus 로고
    • Short-term impact of the switch from immediate-release to extended-release oxcarbazepine in epilepsy patients on high dosages
    • Steinhoff BJ, Wendling AS (2009) Short-term impact of the switch from immediate-release to extended-release oxcarbazepine in epilepsy patients on high dosages. Epilepsy Res 87:256-259
    • (2009) Epilepsy Res , vol.87 , pp. 256-259
    • Steinhoff, B.J.1    Wendling, A.S.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.